Π—Π°ΠΊΠ°Π·Π°Ρ‚ΡŒ курсовыС, ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒΠ½Ρ‹Π΅, Ρ€Π΅Ρ„Π΅Ρ€Π°Ρ‚Ρ‹...
ΠžΠ±Ρ€Π°Π·ΠΎΠ²Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ Ρ€Π°Π±ΠΎΡ‚Ρ‹ Π½Π° Π·Π°ΠΊΠ°Π·. НСдорого!

Π›ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Π°. 
БтратСгия лСчСния нСвропатичСского Π±ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ синдрома

Π Π΅Ρ„Π΅Ρ€Π°Ρ‚ΠŸΠΎΠΌΠΎΡ‰ΡŒ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈΠ£Π·Π½Π°Ρ‚ΡŒ ΡΡ‚ΠΎΠΈΠΌΠΎΡΡ‚ΡŒΠΌΠΎΠ΅ΠΉ Ρ€Π°Π±ΠΎΡ‚Ρ‹

Sang C.N., Booher S., Gilron I., Parada S., Max M.B. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials // Anesthesiology. — 2002. — 96 (5). — 1053βˆ’61. Watson C.P., Tyler K.L., Bickers D.R., Millikan L.E., Smith S., Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic… Π§ΠΈΡ‚Π°Ρ‚ΡŒ Π΅Ρ‰Ρ‘ >

Π›ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Π°. БтратСгия лСчСния нСвропатичСского Π±ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ синдрома (Ρ€Π΅Ρ„Π΅Ρ€Π°Ρ‚, курсовая, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒΠ½Π°Ρ)

1. Dworkin R.H., Backonja M., Rowbotham M.C., Allen R.R., Argoff C.R., Bennett G.J. et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations // Arch. Neurol. — 2003. — 60 (11). — 1524−34.

2. Sindrup S.H., Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action // Pain. — 1999. — 83 (3). — 389−400.

3. McQuay H., Carroll D., Jadad A.R., Wiffen P., Moore A. Anticonvulsant drugs for management of pain: a systematic review (see comments) // BMJ. — 1995. — 311 (7012). — 1047−52.

4. McQuay H.J., Tramer M., Nye B.A., Carroll D., Wiffen P.J., Moore R.A. A systematic review of antidepressants in neuropathic pain // Pain. — 1996. — 68(2−3). — 217−27.

5. Max M.B. Treatment of post-herpetic neuralgia: antidepressants // Ann. Neurol. — 1994. — 35, suppl. — S50−3.

6. Rowbotham M.C., Goli V., Kunz N.R., Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study // Pain. — 2004. -110 (3). — 697−706.

7. Goldstein D.J., Lu Y., Detke M.J., Lee T.C., Lyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy // Pain. — 2005. — 116 (1−2). — 109−18.

8. Dworkin R.H., Corbin A.E., Young J.P. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial // Neurology. — 2003. — 22. — 1274−83.

9. Dworkin R.H., Schmader K.E. Treatment and prevention of postherpetic neuralgia // Clin. Infect. Dis. — 2003. — 36 (7). — 877−82.

10. Harati Y., Gooch C., Swenson M., Edelman S., Greene D., Raskin P. et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy (In Process Citation) // Neurology. — 1998. — 50 (6). — 1842−6.

11. Sindrup S.H., Andersen G., Madsen C., Smith T., Brosen K., Jensen T.S. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial // Pain. — 1999. — 83 (1). — 85−90.

12. Gimbel J.S., Richards P., Portenoy R.K. Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial // Neurology. — 2003. — 60 (6). — 927−34.

13. Raja S.N., Haythornthwaite J.A., Pappagallo M., Clark M.R., Travison T.G., Sabeen S. et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial // Neurology. — 2002. — 59 (7). — 1015−21.

14. Rowbotham M.C., Twilling L., Davies P. S., Reisner L., Taylor K., Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain // N. Engl. J. Med. — 2003. — 348 (13). — 1223−32.

15. Watson C.P., Tyler K.L., Bickers D.R., Millikan L.E., Smith S., Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia // Clin. Ther. — 1993. — 15 (3). — 510−26.

16. Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group // Arch. Intern. Med. — 1991. — 151 (11). — 2225−9.

17. Galer B.S., Rowbotham M.C., Perander J., Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study // Pain. — 1999. — 80 (3). — 533−8.

18. Meier T., Wasner G., Faust M., Kuntzer T., Ochsner F., Hueppe M. et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study // Pain. — 2003. — 106 (1−2). — 151−8.

19. Rowbotham M.C., Davies P. S., Verkempinck C., Galer B.S. Lidocaine patch: double-blind controlled study of a new treatment method for postherpetic neuralgia // Pain. — 1996. — 65 (1). — 39−44.

20. Eide K., Stubhaug A., Oye I., Breivik H. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia // Pain. — 1995. — 61 (2). — 221.

21. Nelson K.A., Park K.M., Robinovitz E., Tsigos C., Max M.B. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia // Neurology. — 1997. — 48 (5). — 1212−8.

22. Sang C.N., Booher S., Gilron I., Parada S., Max M.B. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials // Anesthesiology. — 2002. — 96 (5). — 1053−61.

23. McQuay H.J., Carroll D., Jadad A.R., Glynn C.J., Jack T., Moore R.A. et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design // Pain. — 1994. — 59 (1). — 127−33.

24. Sindrup S.H., Jensen T.S. Pharmacologic treatment of pain in polyneuropathy // Neurology. — 2000. — 55 (7). — 915−20.

25. Adami S., Fossaluzza V., Gatti D., Fracassi E., Braga V. Bisphosphonate therapy of reflex sympathetic dystrophy syndrome / Ann. Rheum. Dis. — 1997. — 56 (3). — 201−4.

26. Baron R. Disease mechanisms in neuropathic pain — a clinical perspective // Nat. Clin. Pract. Neurol., in press.

ΠŸΠΎΠΊΠ°Π·Π°Ρ‚ΡŒ вСсь тСкст
Π—Π°ΠΏΠΎΠ»Π½ΠΈΡ‚ΡŒ Ρ„ΠΎΡ€ΠΌΡƒ Ρ‚Π΅ΠΊΡƒΡ‰Π΅ΠΉ Ρ€Π°Π±ΠΎΡ‚ΠΎΠΉ